Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturing
This review focuses on the emerging monoclonal antibody market for infectious diseases and the metric ton scale manufacturing requirements to meet global demand. Increasing access to existing antibody-based products coupled with the unmet need in infectious disease will likely exceed the current exi...
Saved in:
Main Authors: | Kevin J Whaley (Author), Larry Zeitlin (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reproducibility and flexibility of monoclonal antibody production with Nicotiana benthamiana
by: Kelsi Swope, et al.
Published: (2022) -
Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies.
by: Angelene F Richards, et al.
Published: (2020) -
A call for constructing a metric for monitoring CA-MRSA and other infectious diseases
by: Alaa Al Amiry
Published: (2020) -
Mapping populations at risk: improving spatial demographic data for infectious disease modeling and metric derivation
by: Tatem Andrew J, et al.
Published: (2012) -
Emergence of infectious diseases
Published: (2018)